AJP - Regu AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 271: R863-R869, 1996;
0363-6119/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carroll, M. A.
Right arrow Articles by McGiff, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carroll, M. A.
Right arrow Articles by McGiff, J. C.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 4 863-R869, Copyright © 1996 by American Physiological Society


ARTICLES

Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides

M. A. Carroll, M. Balazy, P. Margiotta, D. D. Huang, J. R. Falck and J. C. McGiff
Department of Pharmacology, New York Medical College, Valhalla 10595, USA.

The cytochrome P-450 pathway is capable of metabolizing arachidonic acid to omega- and subterminal hydroxylase metabolites, 16-, 17-, 18-, 19-, and 20-hydroxyeicosatetraenoic acids (P-450 HETEs). We have quantitated, by gas chromatography-mass spectrometry (GC/MS), endogenous HETEs exiting the rabbit isolated perfused kidney elicited by hormonal stimulation. Kidneys were perfused with Krebs-Henseleit solution containing indomethacin (2.8 microM) to prevent further metabolism of HETEs by cyclooxygenase. Phenylephrine (2-3 microM) was added to the perfusate to raise perfusion pressure to approximately 80 mmHg. Angiotensin II (ANG II), arginine vasopressin (AVP), and bradykinin (BK) were injected into the renal artery and perfusates collected throughout the vasoactive response. After addition of an internal standard, deuterated 19-HETE, perfusates were extracted and purified and P-450 HETEs were derivatized for GC/MS analysis. Under basal conditions, 16-, 18-, 19-, and 20-HETEs were released (range: 50-270 pg/ml), 19-HETE being the highest and fivefold greater than 16-HETE, the lowest. Injection of 50 ng ANG II increased by two- to sixfold P-450 HETE release associated with an increase of 40 +/- 11 mmHg in perfusion pressure. An equipressor dose of AVP (50 ng) did not release P-450 HETEs nor did a 5-micrograms dose of the vasodilator peptide BK, which decreased perfusion pressure by 22 +/- 6 mmHg. Authentic 19- and 20-HETE isomers resulted in dose-dependent dilation, as did 18(R)- and 16(R)-HETEs, whereas their enantiomers and 17-HETE isomers were without effect on perfusion pressure. The vasodilator effects of 18(R)- and 16(R)-HETEs, like 20- and 19-HETEs, were inhibited by indomethacin. Furthermore, P-450 HETEs exhibited both regio- and stereoselective inhibition of proximal tubule adenosine triphosphatase (ATPase) activity. The (S) enantiomers of 16- and 17-HETE potently inhibited activity, whereas their (R) isomers and other P-450 HETEs had negligible effects on ATPase activity. The quantity of HETEs released from the kidney, either under basal conditions or when stimulated by ANG II, and their biological profile suggest that subterminal HETEs may participate in renal mechanisms affecting vasomotion and tubular transport.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. Magnusson, C. M. Sorensen, T. H. Braunstein, N.-H. Holstein-Rathlou, and M. Salomonsson
Renovascular BKCa channels are not activated in vivo under resting conditions and during agonist stimulation
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R345 - R353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff
Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman
Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll
Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. O. Oyekan
Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1289 - 1295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
N. W. Rajapakse, R. J. Roman, J. R. Falck, J. J. Oliver, and R. G. Evans
Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R181 - R187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. K. Cheng, J. C. McGiff, and M. A. Carroll
Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase
Am J Physiol Renal Physiol, March 1, 2003; 284(3): F474 - F479.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R.-M. Gu and W.-H. Wang
Arachidonic acid inhibits K channels in basolateral membrane of the thick ascending limb
Am J Physiol Renal Physiol, September 1, 2002; 283(3): F407 - F414.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman
Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C.-C. Tsao, S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot, J. A. Goldstein, and D. C. Zeldin
Identification and Localization of Five CYP2Cs in Murine Extrahepatic Tissues and Their Metabolism of Arachidonic Acid to Regio- and Stereoselective Products
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Bautista, A. Sanchez, J. Hernandez, A. Oyekan, and B. Escalante
Angiotensin II Type AT2 Receptor mRNA Expression and Renal Vasodilatation Are Increased in Renal Failure
Hypertension, September 1, 2001; 38(3): 669 - 673.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. W. Fallet, J. P. Bast, K. Fujiwara, N. Ishii, S. C. Sansom, and P. K. Carmines
Influence of Ca2+-activated K+ channels on rat renal arteriolar responses to depolarizing agonists
Am J Physiol Renal Physiol, April 1, 2001; 280(4): F583 - F591.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M. A Carroll and J. C McGiff
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
Thorax, October 1, 2000; 55(90002): 13S - 16.
[Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
K. D. Croft, J. C. McGiff, A. Sanchez-Mendoza, and M. A. Carroll
Angiotensin II releases 20-HETE from rat renal microvessels
Am J Physiol Renal Physiol, September 1, 2000; 279(3): F544 - F551.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-C. Tsao, J. Foley, S. J. Coulter, R. Maronpot, D. C. Zeldin, and J. A. Goldstein
CYP2C40, a Unique Arachidonic Acid 16-Hydroxylase, Is the Major CYP2C in Murine Intestinal Tract
Mol. Pharmacol., August 1, 2000; 58(2): 279 - 287.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. Frisbee, J. R. Falck, and J. H. Lombard
Contribution of cytochrome P-450 omega -hydroxylase to altered arteriolar reactivity with high-salt diet and hypertension
Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1517 - H1526.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. H. Capdevila, J. R. Falck, and R. C. Harris
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
J. Lipid Res., February 1, 2000; 41(2): 163 - 181.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. C. McGiff and J. Quilley
20-HETE and the kidney: resolution of old problems and new beginnings
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. Qu, R. A. Rippe, J. Ma, P. Scarborough, C. Biagini, F. T. Fiedorek, G. S. Travlos, C. Parker, and D. C. Zeldin
Nutritional Status Modulates Rat Liver Cytochrome P450 Arachidonic Acid Metabolism
Mol. Pharmacol., September 1, 1998; 54(3): 504 - 513.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. O. Oyekan and J. C. McGiff
Cytochrome P-450-derived eicosanoids participate in the renal functional effects of ET-1 in the anesthetized rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R52 - R61.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Lange, D. Gebremedhin, J. Narayanan, and D. Harder
20-Hydroxyeicosatetraenoic Acid-induced Vasoconstriction and Inhibition of Potassium Current in Cerebral Vascular Smooth Muscle Is Dependent on Activation of Protein Kinase C
J. Biol. Chem., October 24, 1997; 272(43): 27345 - 27352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al.
Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain
J. Biol. Chem., June 29, 2001; 276(27): 25467 - 25479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online